Solutions Focused Full-Service CRO Specialising In Ophthalmology, Oncology, And Rare Disease
We're a comprehensive CRO specialising in ophthalmology, oncology, rare diseases and gene & cell therapy.
Customised Solutions for your Clinical Trial
Agile Approach
GreenLight Clinical
At GreenLight Clinical, we tailor our services to suit the unique requirements of our sponsors, especially small and mid-sized biotech firms. With our agile and adaptable approach, we accommodate diverse study needs and timelines, ensuring seamless and successful trial execution. Reach out today to discover how we can assist with your clinical trial endeavours.
“GLC has been instrumental in all phases of our clinical study. With their leadership, we were able to navigate the regulatory stages and get our study operational with a level of efficiency and quality that would not have been achievable on our own. Further, GLC has provided valuable continuity to our clinical operations with data management, study oversight, and monitoring services.”
- Long Bridge Medical
“During our phase 1 study the GLC team went above and beyond as a true partner and helped us solve challenges along the way in a very short time frame. GLC was an effective link between us as the sponsor and the trial site. The collaboration was always constructive and solution oriented, they worked smart and fast.”
- Biosergen
“GLC team, this is a humongous thank you for your endurance and dedication to move our C-100-001 and C-200-001 projects across the finishing line!"
- Surface Ophthalmics
Solutions for Safe and Effective Outcomes
GreenLight Clinical is a solutions focused Clinical CRO, specialising in Ophthalmology, Oncology & Rare Disease. Our full-service solutions are designed to simplify the clinical trial process, while ensuring safe and effective outcomes.
When you opt for GreenLight Clinical for your clinical trial requirements, you gain the advantage of conducting your trial in Australia, which offers numerous benefits:
Australia provides a research and development tax incentive, fostering innovation and investment in clinical research.
Certain trials benefit from expedited regulatory processes, allowing for quicker trial initiation and completion.
Australia boasts advanced healthcare facilities and services, ensuring top-tier care for trial participants.
Australia's multicultural society offers access to a diverse pool of participants, enhancing the generalizability of trial results.
Australia's stable political and economic climate provides a secure and conducive setting for clinical research activities.
Collaboration with renowned experts in various fields facilitates expert guidance and insight throughout the trial process.
Stringent national data security laws ensure the protection of participant data, maintaining confidentiality and compliance.
Australia's reputation for excellence in research fosters collaboration with global partners, enriching the trial experience and outcomes.
Access to diverse seasonal considerations provides valuable insights into the impact of seasonal factors on diseases and treatments.
Australia offers competitive pricing, ensuring cost-effective trial management without compromising quality.
These advantages position Australia as an appealing destination for clinical trials, and GreenLight Clinical is poised to help you leverage these benefits effectively.
GreenLight Clinical is a physician-led, solutions focused, clinical Contract Research Organisation (CRO) headquartered in Sydney, Australia.
We have offices in Australia and the USA, and a presence in the APAC region.
Our Commitment to Quality and Compliance
At GreenLight Clinical, our dedication to excellence is unwavering. We uphold the utmost standards of quality and compliance across every facet of our operations. Our team adheres strictly to ICH Good Clinical Practice (GCP) guidelines and holds ISO9001 Management System Accreditation. We diligently adhere to both local and international regulations to safeguard the safety and integrity of our clinical trials. Through regular audits and inspections, we continuously evaluate our performance and implement necessary enhancements. This steadfast commitment not only ensures the success of our trials but also fosters ethical standards in healthcare research.
